TCG Crossover Management »

Adverum Biotechnologies shares owned by TCG Crossover Management

Quarter-by-quarter ownership of Adverum Biotechnologies (ADVM) shares owned by TCG Crossover Management from 13F filings

Historical chart of TCG Crossover Management investment in Adverum Biotechnologies

Tip: Access up to 7 years of quarterly data

All positions including Adverum Biotechnologies held by TCG Crossover Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adverum Biotechnologies by TCG Crossover Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $7.6M 1.7M 4.53
2025-06-30 $3.9M 1.8M 2.15
2025-03-31 $7.9M 1.8M 4.37
2024-12-31 $8.4M 1.8M 4.67
2024-09-30 $14M 2.0M 7.02

More positions owned by TCG Crossover Management

Abivax Sa American Depositary Shares Adrs (ABVX)
Cg Oncology Comm (CGON)
Cogent Biosciences Comm (COGT)
Amylyx Pharmaceuticals Comm (AMLX)
Centessa Pharmaceuticals Adrs (CNTA)
Tango Therapeutics Comm (TNGX)
Ocular Therapeutix Comm (OCUL)
Dianthus Therapeutics Comm (DNTH)
Tourmaline Bio Comm (TRML)
Dyne Therapeutics Comm (DYN)
Agios Pharmaceuticals Comm (AGIO)
Eyepoint Pharmaceuticals Comm (EYPT)
Fulcrum Therapeutics Comm (FULC)
Savara Comm (SVRA)
Rapt Therapeutics Comm (RAPT)

View all positions for TCG Crossover Management

Top funds holding Adverum Biotechnologies

BML Capital Management
Frazier Life Sciences Management
Principia Wealth Advisory
TCG Crossover Management
Vanguard Group
5AM Venture Management
Goldman Sachs Group
Renaissance Technologies
Pale Fire Capital SE
Millennium Management
BlackRock
Soleus Capital Management
Dimensional Fund Advisors
Geode Capital Management
Regeneron Pharmaceuticals

View all funds holding Adverum Biotechnologies